# A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers

> **NCT01637285** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 49 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** PF-04856883
- **BIOLOGICAL:** PF-04856883
- **BIOLOGICAL:** PF-04856883
- **BIOLOGICAL:** PF-04856883

## Key facts

- **NCT ID:** NCT01637285
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2015-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01637285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01637285, "A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01637285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*